Skip to main content
Signal8
Launch Terminal
Goodwin Charles D. II profile photo

Charles D. Goodwin II

CIK: 0001726988

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Apyx Medical Corp logo
APYX

Apyx Medical Corp

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Apyx Medical Corp logo
    APYX

    Apyx Medical Corp

    Jun 11, 2026
    Award(A)

    Stock Option (Option to Buy)

    Direct
    213.9K shares-
  • Apyx Medical Corp logo
    APYX

    Apyx Medical Corp

    May 15, 2025
    Award(A)

    Stock Option (Option to Buy)

    Direct
    193K shares-
  • Apyx Medical Corp logo
    APYX

    Apyx Medical Corp

    Jan 15, 2025
    Award(A)

    Stock Option (Option to Buy)

    Direct
    50K shares-

1-3 of 3

About Goodwin Charles D. II

Goodwin Charles D. II (SEC CIK 0001726988) files insider reports with the SEC as Chief Executive Officer of Apyx Medical Corp (APYX).

Signal8 holds 3 ownership filings by Goodwin Charles D. II, all Form 4s, filed between Jan 17, 2025 and Jun 15, 2026. Those filings report 3 transactions, from Jan 15, 2025 to Jun 11, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Goodwin Charles D. II's filings is in CLEARWATER, FL.

Recent filings by Goodwin Charles D. II

  • Jun 11, 2026: Grant or award of APYX derivative securities (Form 4, code A).
  • May 15, 2025: Grant or award of APYX derivative securities (Form 4, code A).
  • Jan 15, 2025: Grant or award of APYX derivative securities (Form 4, code A).

Other insiders filing for Apyx Medical Corp (APYX)

How to read Form 4 transaction codes